Literature DB >> 19729021

Immunomodulation and matrix metalloproteinases in viral myocarditis.

Dirk Westermann1, Konstantinos Savvatis, Heinz-Peter Schultheiss, Carsten Tschöpe.   

Abstract

Myocarditis is an inflammatory disorder induced most commonly by infectious agents. The natural course of the disease is broad and ranges from complete recovery to dilated cardiomyopathy and death. The mechanisms of the incomplete recovery remain poorly understood but extracellular matrix remodelling by metalloproteinases seems to be important for the progression to dilated cardiomyopathy and chronic heart failure. The matrix metalloproteinases (MMPs) are proteolytic enzymes whose role was thought to be the degradation of matrix components only. In the last few years a considerable amount of evidence has gathered which shows new functions of the MMPs as powerful modulatory factors in inflammatory disorders. MMPs facilitate the migration of immune cells through the basement membrane, process cytokines and chemokines by modulating their function, and regulate the relationship of cells with ECM components. These findings enhance our knowledge of the role of MMPs in viral myocarditis and inflammatory cardiomyopathy and may lead to a new understanding which might allow for specific and successful therapeutic interventions in the future. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729021     DOI: 10.1016/j.yjmcc.2009.08.019

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  16 in total

Review 1.  Extracellular Matrix-Based Strategies for Immunomodulatory Biomaterials Engineering.

Authors:  Andrew T Rowley; Raji R Nagalla; Szu-Wen Wang; Wendy F Liu
Journal:  Adv Healthc Mater       Date:  2019-02-04       Impact factor: 9.933

Review 2.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

Review 3.  Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair.

Authors:  William P Lafuse; Daniel J Wozniak; Murugesan V S Rajaram
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

4.  Understanding the role of the extracellular matrix in cardiovascular development and disease: where do we go from here?

Authors:  Merry L Lindsey; Thomas K Borg
Journal:  J Mol Cell Cardiol       Date:  2009-09-23       Impact factor: 5.000

5.  Protective Function of STAT3 in CVB3-Induced Myocarditis.

Authors:  Diana Lindner; Moritz Hilbrandt; Katharina Marggraf; P Moritz Becher; Denise Hilfiker-Kleiner; Karin Klingel; Matthias Pauschinger; Heinz-Peter Schultheiss; Carsten Tschöpe; Dirk Westermann
Journal:  Cardiol Res Pract       Date:  2012-05-24       Impact factor: 1.866

6.  Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis.

Authors:  Hai-Yan Pan; Hirotsugu Yamada; Junji Chida; Siye Wang; Mihiro Yano; Min Yao; Jianhua Zhu; Hiroshi Kido
Journal:  Cardiovasc Res       Date:  2010-11-16       Impact factor: 10.787

7.  The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy.

Authors:  Li Yue-Chun; Chen Guang-Yi; Ge Li-Sha; Xing Chao; Tian Xinqiao; Lin Cong; Dai Xiao-Ya; Yang Xiangjun
Journal:  Front Pharmacol       Date:  2016-11-01       Impact factor: 5.810

8.  Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Sebastian Jäger; Robert Arndt; Tobias Trippel; Irene Müller; Ahmed Elsanhoury; Susanne Rutschow; Stefan D Anker; Heinz-Peter Schultheiss; Matthias Pauschinger; Frank Spillmann; Kathleen Pappritz
Journal:  ESC Heart Fail       Date:  2020-07-14

9.  Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis.

Authors:  Xiaoli Yang; Yan Yue; Sidong Xiong
Journal:  Front Cell Infect Microbiol       Date:  2019-03-07       Impact factor: 5.293

10.  Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors.

Authors:  G Weiss; C Lai; M E Fife; A M Grabiec; B Tildy; R J Snelgrove; G Xin; C M Lloyd; T Hussell
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.